Successful Treatment of Severe Tuberculosis With Contezolid Add‐On Regimen in a Patient Complicated With Acute Thrombocytopenia: A Case Report
Liuqing Zhou, Yimin Wang, Jixue Zhou
Clinical Case Reports · 2024-12
Abstract
ABSTRACT Polypharmacy in managing severe tuberculosis patients usually poses a risk of adverse drug reactions. Contezolid is a new oxazolidinone antibiotic showing good in vitro and in vivo activity against Mycobacterium tuberculosis . Contezolid add‐on regimen shows promising efficacy and safety results in managing severe tuberculosis patients complicated with acute thrombocytopenia.
MeSH terms
- Medicine
- Regimen
- Tuberculosis
- Polypharmacy
- Mycobacterium tuberculosis
- Adverse effect
- Intensive care medicine
- Drug